Molecular progression to cervical precancer, epigenetic switch or sequential model?

Area of Science:

• Gynecologic Oncology
• Molecular Pathology
• Epigenetics

Background:

• The progression pathway of precancerous cervical lesions, specifically cervical intraepithelial neoplasia grade 3 (CIN3), remains incompletely understood.
• Two competing models exist: sequential progression (Normal → CIN1 → CIN2 → CIN3) and the "molecular switch" model (Normal → CIN3 directly).

Purpose of the Study:

• To investigate the DNA methylation profiles of human biomarkers and human papillomavirus (HPV) types in different CIN1 lesion types.
• To compare methylation patterns in CIN1 adjacent to CIN3 versus CIN1 as the primary lesion to differentiate between disease progression models.

Main Methods:

• Quantitative pyrosequencing of bisulfite-converted DNA was used to determine methylation status.
• Analysis focused on the EPB41L3 gene and specific HPV viral regions (HPV16, 18, 31, 33).
• DNA methylation and HPV typing were performed on 354 CIN (CIN1 and CIN3) and normal tissue samples from 127 women undergoing loop electrosurgical excision procedures (LEEP).

Main Results:

• A significant trend of increasing DNA methylation was observed with increasing disease grade (Normal < CIN1 < CIN3).
• Adjacent-CIN1 lesions shared HPV types with associated CIN3, but displayed distinct methylation patterns compared to CIN3 (p=0.008).
• Diagnostically principal-CIN1 lesions showed methylation distributions indistinguishable from adjacent-CIN1, suggesting similar epigenetic origins.

Conclusions:

• The findings support the "molecular switch" model, indicating that progression to CIN1 or CIN3 from normal epithelium often involves distinct DNA epigenotypes, even with the same HPV type.
• This suggests that HPV-driven cervical carcinogenesis may not always follow a strictly sequential pathway.